Poster Abstract Session:
209. Vaccines to Prevent Hepatitis and Gastroenteritis
Saturday, October 20, 2012: 12:30 PM-2:00 PM
Room: SDCC Poster Hall F-H

Topical Category: I. Adult and Pediatric Vaccines and P. Pediatric and Perinatal Infections

Tracks: Adult ID, Pediatric ID

Presentations:

Clinical Safety of VAQTA™
Andrew Wen-Tseng Lee, MD ; Maria Petrecz, BSBA, MLT(ASCP) ; Jon Stek, MS ; Paula Annunziato, MD ; Stephanie Klopfer, PhD

Changes in Seroprevalence of Hepatitis A Antibody among U.S. Children and Adolescents (Age 6-19 Years), 2003-2010
Deanna Kruszon-Moran, MS ; Monina Klevens, DDS, MPH ; Geraldine McQuillan, PhD
Posters
  • HepA_poster.pdf (1.3 MB)

  • Persistence of Antibodies (ab) Anti-Hepatitis A (Anti-HA), 14 Years After Two Doses of Inactivated HA Vaccine, in Argentinean Children
    Eduardo L López, MD ; María M Contrini, MD ; Alicia Mistchenko, MD ; Judith Armoni, MD

    Perinatal Hepatitis B Virus Infection in Dallas County: Why Its Continued Occurrence?
    Sibeso Joyner, MPH ; Zachary Ripp, MD ; Emmanuel Vidal, MBBS ; Joseph Cantey, MD ; Gabriela Cantu, MPH ; Wendy Chung, MD, MSPH ; Pablo J. Sanchez, MD ; Jeanne Sheffield, MD

    Regional Differences of the Effect of Rotavirus Vaccination on Childhood Diarrhea-Related Mortality — Mexico, 2003-2010
    Paul Gastanaduy, MD, MPH ; Edgar Sanchez-Uribe, MD ; Marcelino Esparza-Aguilar, MD, MSc ; Rishi Desai, MD, MPH ; Umesh D. Parashar, MBBS, MPH ; Manish Patel, MD ; Vesta Richardson, MD

    Declining Trends in Rotavirus Testing and Infections in Northeast Florida in the Post-vaccine Era
    Sarah Wheeler, MPH, MSN, CIC ; Jan Meires, EdD, FNP, BC ; Patrick Monaghan, PhD ; Mobeen Rathore, MD

    EFFECTIVENESS OF ROTAVIRUS VACCINES IN PREVENTING ACUTE GASTROENTERITIS IN SPAIN: A MATCHED CASE CONTROL STUDY
    Elena Cobos-Carrascosa ; Francisco Gimenez-Sanchez, MD, PhD ; Miguel Sanchez-Forte

    Estimating the duration of natural immunity to norovirus infection
    Kirsten Simmons ; Manoj Gambhir ; Ben A. Lopman, MSc, PhD

    CME Credits:


    Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 17th with the exception of research findings presented at the IDWeek press conferences.